Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Stock Option Activity (Detail)

v3.23.1
Stockholders' Equity - Stock Option Activity (Detail) - USD ($)
3 Months Ended 12 Months Ended
Feb. 28, 2023
Nov. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Granted 113,000  
Service-Based Vesting Condition Options [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Outstanding at November 30, 2022 329,314  
Granted 113,000  
Exercised 0  
Expired/forfeited 0  
Outstanding at February 28, 2022 442,314 329,314
Exercisable at February 28, 2023 320,671  
Outstanding at November 30, 2022, Weighted Average Exercise Price $ 8.36  
Granted, Weighted Average Exercise Price 4.68  
Exercised, Weighted Average Exercise Price 0  
Expired/forfeited, Weighted Average Exercise Price 0  
Outstanding at February 28, 2023, Weighted Average Exercise Price 7.42 $ 8.36
Exercisable at February 28, 2023, Weighted Average Exercise Price $ 7.48  
Outstanding, Weighted Average Remaining Contractual Term (Years) 4 years 6 months 14 days 4 years 8 months 4 days
Exercisable at February 28, 2023, Weighted Average Remaining Contractual Term (Years) 4 years 5 months 15 days  
Outstanding at November 30, 2022, Aggregate Intrinsic Value $ 37,250  
Granted, Aggregate Intrinsic Value 0  
Exercised, Aggregate Intrinsic Value 0  
Expired/forfeited, Aggregate Intrinsic Value 0  
Outstanding at February 28, 2023, Aggregate Intrinsic Value 20,750 $ 37,250
Exercisable at February 28, 2023, Aggregate Intrinsic Value $ 20,750